New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15

Major Drilling Appoints New Operations Officers to Support 10-03-2023, 04:22

Preliminary Injunction Issued in favor of 2ONE® Nicotine Pouches Against Zone Pouches - Imperial are enjoined from engaging in any future sales of the [Zone] product bearing the Bullseye Mark or any colorable imitation or mark confusingly similar product 23-12-2024, 19:00